StockData
Emmaus Life Sciences, Inc. logo

Emmaus Life Sciences, Inc. (EMMA) stock

EMMAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$0.05−0.01 (-14.38%)

Close on Oct 19, 2026Market cap $6.03MP/E –Yield –

Emmaus Life Sciences free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Emmaus Life Sciences's free cash flow for the twelve months ending Dec 31, 2025 was -$12.00K. For fiscal 2025 it was -$12.00K. The highest annual figure on record is -$12.00K in fiscal 2025.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$12.00K–
FY2024Dec 31, 2024-$2.30M–
FY2023Dec 31, 2023-$1.52M–
FY2022Dec 31, 2022-$5.10M–
FY2021Dec 31, 2021-$1.33M–
FY2020Dec 31, 2020-$2.47M–
FY2019Dec 31, 2019-$4.58M–
FY2017Sep 30, 2017-$4.92M–
FY2016Sep 30, 2016-$2.98M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2025CQ4 2025Dec 31, 2025$2.21M–
Q3 FY2025CQ3 2025Sep 30, 2025$409.00K+200.7%
Q4 FY2024CQ4 2024Dec 31, 2024$337.00K-67.3%
Q3 FY2024CQ3 2024Sep 30, 2024$149.00K+156.9%
Q2 FY2024CQ2 2024Jun 30, 2024-$2.92M–
Q1 FY2024CQ1 2024Mar 31, 2024$136.00K–
Q4 FY2023CQ4 2023Dec 31, 2023$1.03M-38.3%
Q3 FY2023CQ3 2023Sep 30, 2023$58.00K–
Q2 FY2023CQ2 2023Jun 30, 2023-$1.31M–
Q1 FY2023CQ1 2023Mar 31, 2023-$1.30M–
Q4 FY2022CQ4 2022Dec 31, 2022$1.67M+107.8%
Q3 FY2022CQ3 2022Sep 30, 2022-$954.00K-158.5%
Q2 FY2022CQ2 2022Jun 30, 2022-$1.08M-156.5%
Q1 FY2022CQ1 2022Mar 31, 2022-$4.74M–
Q4 FY2021CQ4 2021Dec 31, 2021$803.00K–
Q3 FY2021CQ3 2021Sep 30, 2021$1.63M-9.7%
Q4 FY2020CQ4 2020Dec 31, 2020$1.91M–
Q3 FY2020CQ3 2020Sep 30, 2020-$2.64M–
Q2 FY2020CQ2 2020Jun 30, 2020-$3.54M–
Q1 FY2020CQ1 2020Mar 31, 2020$1.81M–
Q4 FY2019CQ4 2019Dec 31, 2019-$3.30M–
Q3 FY2019CQ3 2018Jun 30, 2019-$86.00K–
Q4 FY2017CQ3 2017Sep 30, 2017-$2.16M–
Q3 FY2017CQ2 2017Jun 30, 2017-$1.07M–
Q2 FY2017CQ1 2017Mar 31, 2017-$918.50K–
Q1 FY2017CQ4 2016Dec 31, 2016-$767.40K–
Q4 FY2016CQ3 2016Sep 30, 2016-$949.70K–
Q3 FY2016CQ2 2016Jun 30, 2016-$691.80K–

More Emmaus Life Sciences figures

See a number that looks wrong?